CAS: 86-21-5; N,N-Dimethyl-3-Phenyl-3-(Pyridin-2-yl)Propan-1-Amine

该化合物是一种属于甲胺类的抗口炎,主要用于缓解鼻鼻,喷嚏和痒等过敏症状;是一种种族混合物,意思是两种抗菌剂的同等部分,可以显示不同的生物活动;该化合物的特征是能够阻塞H1抗胺受体,从而减少体内的甲胺影响;苯胺一般是口服的,可以使用各种配方,包括药片和糖浆;其化学结构包括一个苯环和一个矿体,有助于其药理特性;该物质一般都很好地发酵,但可能会产生副作用,如沉睡,口干口和晕眩等,因为其抗胆炎作用;与任何药物一样,在保健专业人员的指导下使用苯胺非常重要,特别是在有前期状况的人或其他药物患者中.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号124-40-3 二甲胺 | CAS号50599-78-5 4-(dimethylamin... | CAS号74-86-2 乙炔 | CAS号15260-65-8 2-(1-phenylethe... | CAS号201230-82-2 carbon monoxide | CAS号35344-68-4 dimethyl-(3-phe... | CAS号42817-44-7 N,N-dimethyl-3-...

合成工艺路线路线简述

  • 15260-65-8 = 86-21-5
    反应条件:1.1 Catalysts: Chloro[(1,2,5,6-η)-1,5-Cyclooctadiene][1,3-Dihydro-1,3-Bis(2,4,6-Trimethylphenyl... Solvents: Toluene; Rt1.2 Reagents: Hydrogen; 24 H,60 Bar,125 °C; 125 °C -> Rt
    标题:Hydroaminomethylation With Novel Rhodium-Carbene Complexes: An Efficient Catalytic Approach To Pharmaceuticals
    作者:Ahmed,Moballigh; Et Al
    参考文献:Chemistry - A European Journal 日期:2007 卷标:13(5) 页码:1594-1601]

    = 86-21-5
    反应条件:1.1 Reagents: Methylmagnesium Bromide Solvents: Diethyl Ether,Tetrahydrofuran; Rt; 1 H,Rt1.2 Reagents: Hydrochloric Acid Solvents: Methanol
    标题:Versatile C(Sp2)-C(Sp3) Ligand Couplings Of Sulfoxides For The Enantioselective Synthesis Of Diarylalkanes
    作者:Dean,William M.; Et Al
    参考文献:Angewandte Chemie 日期:2016 卷标:55(34) 页码:10013-10016]

    15260-65-8 + 2248408-49-1 = 86-21-5
    反应条件:1.1 Reagents: Hantzsch Ester Catalysts: 2489222-42-4 (Solid Solution With Triflate Analog) Solvents: Acetonitrile; 6 H,Rt
    标题:Metal-Organic Framework With Dual Active Sites In Engineered Mesopores For Bioinspired Synergistic Catalysis
    作者:Quan,Yangjian; Et Al
    参考文献:Journal Of The American Chemical Society 日期:2020 卷标:142(19) 页码:8602-8607]

    35344-68-4 = 86-21-5 [标题:Reaction Conditions
    标题:Photoredox-Catalyzed Branch-Selective Pyridylation Of Alkenes For The Expedient Synthesis Of Triprolidine
    作者:Zhu,Shengqing; Et Al
    参考文献:Nature Communications 日期:2019 卷标:10(1) 页码:1-7]

    100-70-9 + 42817-44-7 = 86-21-5
    反应条件:1.1 Reagents: Sodium 4-Chlorobenzenesulfonate,Ammonium Chloride Catalysts: Tris[2-(2-Pyridinyl-Kn)Phenyl-Kc]Iridium Solvents: Ethanol,Acetonitrile; 2 H,25 °C1.2 Reagents: Potassium Methoxide; 1 H,25 °C1.3 Reagents: Water2.1 -
    标题:Photoredox-Catalyzed Branch-Selective Pyridylation Of Alkenes For The Expedient Synthesis Of Triprolidine
    作者:Zhu,Shengqing; Et Al
    参考文献:Nature Communications 日期:2019 卷标:10(1) 页码:1-7]

    1779-49-3 + 91-02-1 = 86-21-5
    反应条件:1.1 Reagents: Potassium Tert-Butoxide Solvents: Tetrahydrofuran; 30 Min,0 °C1.2 0 °C; 0 °C -> Rt; Overnight,Rt1.3 Reagents: Water; Rt2.1 Reagents: 1,8-Diazabicyclo[5.4.0]Undec-7-Ene Catalysts: Iridium(1+),[4,4′-Bis(1,1-Dimethylethyl)-2,2′-Bipyridine-Kn1,Kn1′]Bis[3,5-Diflu... Solvents: Dimethylformamide; 24 H,Rt2.2 Reagents: Dichloromethane; Rt
    标题:Anti-Markovnikov Hydro(Amino)Alkylation Of Vinylarenes Via Photoredox Catalysis
    作者:Wu,Zhao; Et Al
    参考文献:Nature Communications 日期:2021 卷标:12(1)]

    101288-62-4 = 86-21-5
    反应条件:1.1 Reagents: (Dimethyl Sulfide)Trihydroboron Solvents: Tetrahydrofuran; 0 °C; Reflux
    标题:Photoinduced Three-Component Carboarylation Of Unactivated Alkenes With Protic C(Sp3)-H Feedstocks
    作者:Hong,Yang; Et Al
    参考文献:Organic Letters 日期:2022 卷标:24(41) 页码:7677-7684]

    50599-78-5 = 86-21-5
    反应条件:1.1 Catalysts: [(1,2,5,6-η)-1,5-Cyclooctadiene](η5-2,4-Cyclopentadien-1-Yl)Cobalt Solvents: Toluene
    标题:New Synthetic Route To Pheniramines Via Hydroformylation Of Functionalyzed Olefins
    作者:Botteghi,Carlo; Et Al
    参考文献:Journal Of Organic Chemistry 日期:1994 卷标:59(23) 页码:7125-7]

    46498-51-5 = 86-21-5
    反应条件:1.1 Catalysts: Bis(Dichloro(η6-P-Cymene)Ruthenium),Bis[2-(Diphenylphosphino)Phenyl] Ether Solvents: Toluene; Rt; 10 Min,Rt; Rt -> Reflux; 24 H,Reflux
    标题:Ruthenium-Catalyzed N-Alkylation Of Amines And Sulfonamides Using Borrowing Hydrogen Methodology
    作者:Hamid,M. Haniti S. A.; Et Al
    参考文献:Journal Of The American Chemical Society 日期:2009 卷标:131(5) 页码:1766-1774]

    46498-51-5 = 86-21-5
    反应条件:1.1 Reagents: Sulfuric Acid Solvents: Benzene
    标题:Aminopropane Derivatives
    参考文献:Germany]

    15260-65-8 + 593-81-7 = 86-21-5
    反应条件:1.1 Reagents: 1,8-Diazabicyclo[5.4.0]Undec-7-Ene Catalysts: Iridium(1+),[4,4′-Bis(1,1-Dimethylethyl)-2,2′-Bipyridine-Kn1,Kn1′]Bis[3,5-Diflu... Solvents: Dimethylformamide; 24 H,Rt1.2 Reagents: Dichloromethane; Rt
    标题:Anti-Markovnikov Hydro(Amino)Alkylation Of Vinylarenes Via Photoredox Catalysis
    作者:Wu,Zhao; Et Al
    参考文献:Nature Communications 日期:2021 卷标:12(1)]

    76132-65-5 = 86-21-5
    反应条件:1.1 Reagents: Cesium Carbonate Catalysts: 2056267-38-8; 48 H,140 °C
    标题:Direct Synthesis Of N,N-Dimethylated And β-Methyl N,N-Dimethylated Amines From Nitriles Using Methanol: Experimental And Computational Studies
    作者:Paul,Bhaskar; Et Al
    参考文献:Acs Catalysis 日期:2018 卷标:8(4) 页码:2890-2896]

    100866-24-8 = 86-21-5
    反应条件:1.1 Reagents: Hydrogen Catalysts: Platinum
    标题:New Synthetic Route To Pheniramines Via Hydroformylation Of Functionalyzed Olefins
    作者:Botteghi,Carlo; Et Al
    参考文献:Journal Of Organic Chemistry 日期:1994 卷标:59(23) 页码:7125-7]

    101-82-6 = 86-21-5
    反应条件:1.1 Reagents: Butyllithium Solvents: Tetrahydrofuran,Hexane; -78 °C; 15 Min,-78 °C1.2 Reagents: Butyllithium Solvents: Tetrahydrofuran,Hexane; -78 °C1.3 -78 °C; -78 °C -> Rt; 24 H,Rt1.4 Solvents: Water2.1 Catalysts: Bis(Dichloro(η6-P-Cymene)Ruthenium),Bis[2-(Diphenylphosphino)Phenyl] Ether Solvents: Toluene; Rt; 10 Min,Rt; Rt -> Reflux; 24 H,Reflux
    标题:Ruthenium-Catalyzed N-Alkylation Of Amines And Sulfonamides Using Borrowing Hydrogen Methodology
    作者:Hamid,M. Haniti S. A.; Et Al
    参考文献:Journal Of The American Chemical Society 日期:2009 卷标:131(5) 页码:1766-1774]

    158696-48-1 = 86-21-5
    反应条件:1.1 Reagents: Hydroxyamine Hydrochloride1.2 Reagents: Carbon Disulfide,Sodium Hydroxide Catalysts: Tetrabutylammonium Hydrogen Sulfate Solvents: Dichloromethane,Water2.1 Catalysts: [(1,2,5,6-η)-1,5-Cyclooctadiene](η5-2,4-Cyclopentadien-1-Yl)Cobalt Solvents: Toluene
    标题:New Synthetic Route To Pheniramines Via Hydroformylation Of Functionalyzed Olefins
    作者:Botteghi,Carlo; Et Al
    参考文献:Journal Of Organic Chemistry 日期:1994 卷标:59(23) 页码:7125-7
二甲基-(3-苯基-3-吡啶-2-基-烯丙基)-胺置于palladium On Activated Charcoal,溶剂黄146体系中,化学反应生成 非尼拉敏
参考文献:Heterocyclic Amino Alcohols
标题:Heterocyclic Amino Alcohols
摘要:通式为3-Tert.-氨基-1-(21-吡啶基)-1-芳基-丙醇的化合物,其中r1代表2-吡啶基,R2代表芳基或芳基的烷氧基或卤素取代的芳基或2-噻吩基,R3和r4可以相同也可以不同,代表含有1至5个碳原子的烷基基团,或nr3R4代表吗啡啉,吡咯啉或哌啶基团,通过处理所需的tert.-氨基乙基芳基酮或其盐与2-吡啶基锂,然后水解所形成的有机锂化合物来制备.该反应可以通过在惰性溶剂(如醚)中形成2-吡啶基锂的溶液或悬浮液,然后在搅拌的同时在惰性气氛中与氨基酮混合来进行.形成的有机锂化合物可以用水和酸(如乙酸或盐酸)水解,然后分离产生的酸性水层,使其碱化,然后用溶剂(如氯仿)提取碱性产物.产物可以通过减压蒸馏或结晶纯化.产物可以转化为水溶性盐.在示例中,制备了以下化合物:3-二甲氨基-1-(21-吡啶基)-1-苯基丙醇及其草酸盐,3-N-吡咯啉-1-苯基-1-(21-吡啶基)-丙醇,3-二甲氨基和3-二乙氨基-1-(41-氯苯基)-1-(211-吡啶基)丙醇,3-N-吡咯啉-1-(41-氯苯基)-1-(211-吡啶基)丙醇,3-二甲氨基-1-(41-甲氧基苯基)-(21-吡啶基)丙醇及其二盐酸盐,以及3-二甲氨基-1-(21-吡啶基)-1-(211-噻吩基)丙醇.在第2节(5)中提供的样品是1-(41-溴苯基)-3-N-吗啡啉-1-(211-吡啶基)-丙醇,以及1-(41-氯苯基)-3-N-哌啶基-1-(211-吡啶基)丙醇.参考规格646,198,689,288和689,289.在临时规范中提到了3-二甲氨基-1-(31-吡啶基)-苯基丙醇和4-N-哌啶基-1-(21-吡啶基)-2-苯基丁醇,它们是通过类似上述方法制备的.2-和3-吡啶基锂是通过将锂与1-氯丁烷反应,然后分别加入2-溴吡啶和3-溴吡啶制备的.b-二甲胺基丙酮是通过乙酰苯酮,二甲胺盐酸盐和甲醛反应制备的.b-二甲胺基-和b-二乙胺基-对氯丙酮是通过对氯苯乙酮,甲醛和二甲胺和二乙胺反应制备的.提到了这些化合物的盐酸盐.b-N-吡咯啉-丙酮是通过苯乙酮,甲醛和吡咯啉反应制备的.提到了盐酸盐.b-N-哌啶基-丙酮(在临时规范中提到)是通过苯乙酮,甲醛和哌啶反应制备的.b-N-吡咯啉-和b-N-哌啶基-对氯丙酮是通过对氯丙酮,甲醛和吡咯啉和哌啶反应制备的.b-N-吗啡啉-对溴-对氯丙酮是通过对溴丙酮,甲醛和吗啡啉反应制备的.

海关参考信息

专利信息


专利号:US-8734846-B2
优先权日:2008-06-16
标 题 :Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
发明人:ALI MIR M; HRKACH JEFF; ZALE STEPHEN E; ALVAREZ DE CIENFUEGOS LUIS
权利人:BIND BIOSCIENCES INC
摘要:This application provides nanoparticles and methods of making nanoparticles using pre-functionalized poly(ethylene glycol)(also referred to as PEG) as a macroinitiator for the synthesis of diblock copolymers. Ring opening polymerization yields the desired poly(ester)-poly (ethylene glycol)-targeting agent polymer that is used to impart targeting capability to therapeutic nanoparticles. This “polymerization fromâ€? approach typically employs precursors of the targeting agent wherein the reactivity of functional groups of the targeting agent is masked using protecting groups. Also described is a “coupling toâ€? that utilized the poly(ethylene glycol)-targeting agent conjugate where the targeting agent remains in its native un-protected form. This method uses “orthogonalâ€? chemistry that exhibit no cross reactivity towards functional groups typically found within targeting agents of interest.

专利号:US-9650407-B2
优先权日:2011-11-02
标 题 :Reprogramming of cellular adhesion
发明人:GARTNER ZEV JORDAN; SELDEN NICHOLAS SCOTT; TODHUNTER MICHAEL E; LIANG SAMANTHA ISABEL; WEBER ROBERT JOSEPH; JEE NOEL YOUNGHO; LIU JENNIFER S
权利人:UNIV CALIFORNIA
摘要:Disclosed are membrane-anchored polynucleotides, and compositions comprising the membrane-anchored polynucleotides. Also disclosed are the processes for the synthesis of these compounds, compositions comprising such compounds, and the use of such compounds and compositions in research and therapeutic applications.

专利号:WO-2023075715-A1
优先权日:2021-10-26
标题 :A pharmaceutical formulation including leukotriene receptor antagonists and/or leukotriene synthesis inhibitors combined with non-steroidal anti-inflammatory drugs (nsaids)
发明人:OYTUN FARUK; CAN EFE
权利人:VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI
摘要:This invention is related to a pharmaceutical formulation including Leukotriene receptor antagonists and/or Leukotriene synthesis inhibitors combined with non-steroidal anti-inflammatory drugs (NSAIDs) and antihistamines in ocular diseases and in inflammatory and allergic diseases for systemic and topical use. The objective of this invention is to create a novel formulation to be effective as much as steroids while having significantly less side effects for long-term use in treating ocular diseases, inflammatory and allergic diseases. In other words our aim is to achieve the inhibition of pro-inflammatory mediators (prostaglandins, thromboxane, histamine and leukotrienes) as much as steroids do with a safer combination.

专利号:US-8697730-B2
优先权日:2007-10-26
标题 :5-lipoxygenase activating protein (FLAP) inhibitor
发明人:REWOLINSKI MELISSA VIRGINIA; SCHAAB KEVIN MURRAY; KING CHRISTOPHER DAVID; STOCK NICHOLAS SIMON
权利人:REWOLINSKI MELISSA VIRGINIA; SCHAAB KEVIN MURRAY; KING CHRISTOPHER DAVID; STOCK NICHOLAS SIMON; PANMIRA PHARMACEUTICALS LLC
摘要:Described herein are methods for the synthesis of 3-[5-(pyridin-2-ylmethoxy)-3-(2-methyl-2-propylthio)-1-[4-(2-methoxypyridin-5-yl)benzyl]-indol-2-yl]-2,2-dimethyl-propionic acid, pharmaceutically acceptable salts, pharmaceutically acceptable solvates thereof. Also described are pharmaceutical compositions suitable for oral administration to a mammal that include, as well as methods of using such oral pharmaceutical compositions for treating respiratory conditions or diseases, as well as other leukotriene-dependent or leukotriene mediated conditions or diseases.

专利号:MX-2009002267-A
优先权日:2006-08-28
标题:PROCEDURE AND INTERMEDIARIES FOR THE SYNTHESIS OF DERIVATIVES AND INTERMEDIARIES OF (3-ALQUIL-5-PIPERIDIN-1-IL-3,3A-DIHIDRO-PIRAZOLO [1,5-A] PIRIMIDIN-7-IL) -AMINO.

专利号:CN-111138350-B
优先权日:2020-01-03
标题 :A kind of asymmetric synthesis method of dexchlorpheniramine and dexbrompheniramine
天津杰众国际贸易有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.visonmed.com
电话: 0086 022 23511660 23358985👤
📞天津杰众国际贸易有限公司 ⚠️参考联系方式

销售电话:0086 022 23511660 23358985
邮箱:info@visonmed.com.
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海瀛正科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.intechem.com
电话: 021-51560106👤
📞上海瀛正科技有限公司 ⚠️参考联系方式

销售电话:021-51560106
邮箱:wj18918939007@yahoo.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Medical Journal of Australia., 2(110), 1976
摘要:P. B. Marshall. Brit. J. Pharmacol. 10, 270 (1955).
摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知